RedHill Biopharma (RDHL) Return on Assets [ROA] (2013 - 2023)
RedHill Biopharma's Return on Assets [ROA] came in at -1.98% for the year ended Dec 31, 2025, up 38.27 percentage points from -40.24% a year earlier.
Powered by 
Analysis
RedHill Biopharma (RDHL) Return on Assets [ROA] (2013 - 2023) Analysis & Trends
Going back to the year ended Dec 31, 2010, RedHill Biopharma's Return on Assets [ROA] data covers 16 years.
- Return on Assets [ROA] carries a five-year change of +57.92 percentage points (years ended Dec 2020 to Dec 2025).
- The five-year range for annual Return on Assets [ROA] is -54.09% (the year ended Dec 31, 2021) to 26.29% (the year ended Dec 31, 2023).
- Per Business Quant, earlier years put Return on Assets [ROA] at -40.24% in the year ended Dec 31, 2024 (-66.54 pp), 26.29% in the year ended Dec 31, 2023 (+68.44 pp), -42.15% in the year ended Dec 31, 2022 (+11.94 pp) and -54.09% in the year ended Dec 31, 2021 (+5.81 pp).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROA (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 20.64% |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 10.47% |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 4.65% |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 2.45% |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 28.37% |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 9.10% |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 9.29% |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | -6.13% |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 2.14% |
| 10 | RedHill Biopharma | 7.38 Mn | 7.38 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2023 | 24.66% |
| Mar 31, 2023 | -93.14% |
| Dec 31, 2022 | -19.37% |
| Sep 30, 2022 | -31.53% |
| Jun 30, 2022 | -22.05% |
| Mar 31, 2022 | -31.22% |
| Dec 31, 2021 | -53.19% |
| Sep 30, 2021 | -50.10% |
| Jun 30, 2021 | -44.81% |
| Mar 31, 2021 | -40.90% |
| Dec 31, 2020 | -43.62% |
| Sep 30, 2020 | -37.89% |
| Jun 30, 2020 | -35.33% |
| Mar 31, 2020 | -45.58% |
| Dec 31, 2019 | -73.99% |
| Sep 30, 2019 | -85.16% |
| Jun 30, 2019 | -71.49% |
| Mar 31, 2019 | -64.30% |
| Dec 31, 2018 | -67.05% |
| Sep 30, 2018 | -91.09% |
API Access
RedHill Biopharma Return on Assets [ROA] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=RDHL&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-assets-[roa]", "ticker": "RDHL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=RDHL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();